Naples, FL, United States of America

Gerald Goldsmith

This inventor holds 2 USPTO granted patents. Top assignee: Arthrex, Gmbh. Active years: 2009-2011.


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gerald Goldsmith: Innovator in Endoscopic Technology

Introduction

Gerald Goldsmith is a notable inventor based in Naples, FL (US). He has made significant contributions to the field of medical technology, particularly in endoscopic devices. With a total of 2 patents to his name, Goldsmith continues to push the boundaries of innovation in healthcare.

Latest Patents

Goldsmith's latest invention is the endoscopic rotary abrader. This device allows for an increased burr size while maintaining the required minimum clearance between the burr and the hood. The design achieves this through either an offset configuration of non-concentric inner and outer tubes, where the inner tube is shifted laterally away from the hood, or by employing an enlarged hood. This innovation enhances the efficiency and effectiveness of endoscopic procedures.

Career Highlights

Goldsmith is currently associated with Arthrex GmbH, a company renowned for its advancements in orthopedic technology. His work at Arthrex has positioned him as a key player in the development of innovative medical devices that improve patient outcomes.

Collaborations

Throughout his career, Goldsmith has collaborated with talented individuals such as Philip S. O'Quinn and Randall Lee Hacker. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Gerald Goldsmith's contributions to endoscopic technology exemplify the spirit of innovation in the medical field. His patents reflect a commitment to improving healthcare through advanced engineering solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…